News

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Detailed price information for Enveric Biosciences Inc (ENVB-Q) from The Globe and Mail including charting and trades.